Quinn William P. — SEC insider filings
SEC reporting owner CIK 1724190. 13 insider filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2021-02-08 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 12 legs across 7 filings — 25,172 shares, $85,874 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 17,566 shares, $58,402 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 9,132 shares @ $3.24 ($29,555) in Bolt Biotherapeutics, Inc., filed 2026-09-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | President, CEO and CFO, Director | 13 | 12 legs · 25,172 sh · $85,874 | 3 legs · 17,566 sh · $58,402 | 24 |
Insider filings — Quinn William P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 637 @ $3.88 · Sale (S): 1,889 @ $3.77 · Sale (S): 6,545 @ $3.32 · Sale (S): 9,132 @ $3.24 | EDGAR |
| 2026-02-04 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $4.61 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 7,614 (derivative) · Disposition to issuer (D): 7,614 (derivative) · Grant/award (A): 3,927 (derivative) · Disposition to issuer (D): 3,927 (derivative) · Grant/award (A): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +10 more | EDGAR |
| 2025-10-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $5.49 · Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-05-05 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 2,500 @ $0.50 · Purchase (P): 2,500 @ $0.64 · Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 440,000 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
| 2023-12-13 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 1,829 @ $1.18 · Purchase (P): 2,500 @ $0.78 · Purchase (P): 7,500 @ $0.95 | EDGAR |
| 2023-02-28 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2021-12-09 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 1,221 @ $16.65 · Purchase (P): 35 @ $4.64 · Purchase (P): 5,000 @ $4.71 | EDGAR |
| 2021-02-09 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 1,200 @ $20 | EDGAR |
| 2021-02-08 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724190 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs